Developing and Testing Interventions to Address Use of Conscientious Objection to Deny Women's Access to Abortion Care in Mexico and South Africa
| Registry | NCT04290832 |
|---|---|
| Status | Terminated - The study was stopped prematurely due to the COVID-19 pandemic |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: none, supportive care |
| Enrollment | 317 (Actual) |
| Sponsor | Ipas (Other) |
| Conditions | Abortion, Induced, Abortion, Incomplete |
| Interventions | CO Intervention (Behavioral) |
| Dates | start 2020-02-13, primary completion 2020-03-17, completion 2020-06-30, first posted 2020-03-02, last updated 2020-07-29 |
| Locations | 2 sites in Mexico, South Africa |
Related Papers Related Patents Related Grants Related Experts
All trials for Abortion, Induced All trials for Abortion, Incomplete All trials of CO Intervention
The primary purpose of this research is to develop strategies and interventions to mitigate the impact of conscientious objection on women's access to safe abortion care in Mexico and South Africa using a user-centered design approach and test the feasibility and effectiveness of these interventions.
Conscientious objection (CO) is emerging as a growing barrier to abortion care, and evidence suggests that it is being incorrectly used as a justification for public sector medical providers and institutions to exempt themselves from their duties to provide essential reproductive health services for women. Given this, it is essential to better understand and address this misuse of CO and find ways to improve women's access to safe abortion services to prevent them from using unsafe methods which risk their health and lives.
This study will conduct formative research to more fully understand the problem of CO in Mexico and South Africa and use these findings to develop interventions and strategies to mitigate the impact of CO on women's access to safe abortion care using a user-centered design approach. Rapid randomized controlled trials will then be used to assess effectiveness of the interventions. The specific aims of this study are:
1. Improve our understanding of CO and its impact on access and quality of abortion care from providers' and facility mangers' perspectives in Mexico, and South Africa.
2. Develop strategies and interventions to mitigate the impact of CO on women's access to safe abortion care. Using the data collected, a multi-disciplinary Innovation Team will develop strategies and interventions to respond to the challenges posed by CO using a user-centered design approach.
3. Rapid-test intervention prototypes. We will test selected strategies (prototypes) in Mexico, and South Africa with assessments to determine successes, and the feasibility of scaling up these approaches.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| CO intervention | Experimental | Behavioral: CO Intervention | South Africa: All health facility staff working in facilities assigned to the intervention arm receive standard Ipas support (including monitoring of abortion service provision and support to Ipas-trained abortion providers) plus the CO intervention. Mexico: Doctors/anyone eligible to be an abortion provider working in facilities assigned to the intervention arm receive the CO intervention. |
| Control | No intervention | South Africa: All health facility staff working in facilities assigned to the control arm receive standard Ipas support (including monitoring of abortion service provision and support to Ipas-trained abortion providers). Mexico: No intervention |
Sex: All, accepts healthy volunteers
South Africa Inclusion Criteria: * All staff currently working in selected health facilities * Able to provide informed consent Exclusion Criteria: * Unable to provide informed consent Mexico Inclusion Criteria: * Doctors/anyone eligible to be an abortion provider working in selected health facilities * Able to provide informed consent Exclusion Criteria: * Unable to provide informed consent
| Facility | City | Country | Status |
|---|---|---|---|
| Ipas Central America and Mexico | Mexico City | Mexico | |
| Ipas South Africa | Johannesburg | South Africa |